微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 0.8% | -58.12% | -85.66% | 73/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 5.58% | 24.55% | -7.92% | 52/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.06% | 12.85% | 77.71% | 45/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.41% | -10.5% | 78.53% | 52/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.91% | -40.68% | -57.37% | 49/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 4.48% | -61.38% | -16.57% | 65/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 5.37% | -51% | 40.94% | 50/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.81% | -53.87% | 18.32% | 53/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.22% | -30.15% | -72.24% | 21/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 11.6% | 48.53% | 5.84% | 24/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 10.96% | 48.51% | 32.69% | 21/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 8.26% | 230.4% | 79.18% | 13/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.61% | 380.21% | -40.97% | 18/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 7.81% | 12.7% | 5.83% | 73/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 7.38% | 8.05% | 195.2% | 69/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.5% | -59.35% | 160.42% | 90/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.96% | -57.89% | -86.15% | 91/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.93% | -49.86% | 1.46% | 95/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.83% | -51.87% | 11.06% | 81/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.15% | 1.65% | 169.74% | 69/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.28% | 30.29% | -83.5% | 67/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 13.82% | 127.3% | -2.61% | 72/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 14.19% | 186.09% | 134.55% | 43/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 6.05% | 249.71% | 245.71% | 64/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.75% | 43.44% | -71.22% | 46/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 6.08% | 261.9% | 22.58% | 91/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.96% | 5.31% | 186.71% | 48/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.73% | -24.45% | 41.8% | 64/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.22% | -35.79% | -27.38% | 41/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 1.68% | -67.38% | -64.33% | 95/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.71% | -27.43% | 105.68% | 38/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 2.29% | -48.54% | 20.53% | 48/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.9% | -28.57% | -63.11% | 34/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 5.15% | -30.5% | -20.65% | 81/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 6.49% | -1.07% | 45.84% | 30/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.45% | 25.71% | 67.29% | 36/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.66% | 4.31% | -64.1% | 18/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 7.41% | 15.24% | 12.96% | 61/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 6.56% | 29.39% | 85.31% | 22/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 3.54% | -8.76% | 38.82% | 33/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 2.55% | 3.66% | -60.34% | 15/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |